Some content of this application is unavailable at the moment.
If this situation persist, please contact us atFeedback&Contact
1. (WO2018221649) APCS-EXPRESSION-SUPPRESSING NUCLEIC ACIDS
Latest bibliographic data on file with the International Bureau    Submit observation

Pub. No.: WO/2018/221649 International Application No.: PCT/JP2018/020941
Publication Date: 06.12.2018 International Filing Date: 31.05.2018
IPC:
C12N 15/113 (2010.01) ,A61K 31/7105 (2006.01) ,A61K 31/713 (2006.01) ,A61K 48/00 (2006.01) ,A61P 3/00 (2006.01)
C CHEMISTRY; METALLURGY
12
BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
N
MICRO-ORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICRO-ORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
15
Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
09
Recombinant DNA-technology
11
DNA or RNA fragments; Modified forms thereof
113
Non-coding nucleic acids modulating the expression of genes, e.g. antisense oligonucleotides
A HUMAN NECESSITIES
61
MEDICAL OR VETERINARY SCIENCE; HYGIENE
K
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
31
Medicinal preparations containing organic active ingredients
70
Carbohydrates; Sugars; Derivatives thereof
7088
Compounds having three or more nucleosides or nucleotides
7105
Natural ribonucleic acids, i.e. containing only riboses attached to adenine, guanine, cytosine or uracil and having 3'-5' phosphodiester links
A HUMAN NECESSITIES
61
MEDICAL OR VETERINARY SCIENCE; HYGIENE
K
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
31
Medicinal preparations containing organic active ingredients
70
Carbohydrates; Sugars; Derivatives thereof
7088
Compounds having three or more nucleosides or nucleotides
713
Double-stranded nucleic acids or oligonucleotides
A HUMAN NECESSITIES
61
MEDICAL OR VETERINARY SCIENCE; HYGIENE
K
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
48
Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy
A HUMAN NECESSITIES
61
MEDICAL OR VETERINARY SCIENCE; HYGIENE
P
SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
3
Drugs for disorders of the metabolism
Applicants:
協和発酵キリン株式会社 KYOWA HAKKO KIRIN CO., LTD. [JP/JP]; 東京都千代田区大手町一丁目6番1号 1-6-1, Otemachi, Chiyoda-ku, Tokyo 1008185, JP
Inventors:
有山 博之 ARIYAMA, Hiroyuki; JP
村上 拓也 MURAKAMI, Takuya; JP
今枝 隆 IMAEDA, Takashi; JP
宮澤 達也 MIYAZAWA, Tatsuya; JP
Agent:
稲葉 良幸 INABA, Yoshiyuki; JP
大貫 敏史 ONUKI, Toshifumi; JP
Priority Data:
2017-10850231.05.2017JP
Title (EN) APCS-EXPRESSION-SUPPRESSING NUCLEIC ACIDS
(FR) ACIDES NUCLÉIQUES SUPPRESSEURS DE L'EXPRESSION D'APCS
(JA) APCSの発現を抑制する核酸
Abstract:
(EN) The present invention provides double-stranded nucleic acids that suppress the expression of the APCS gene, the double-stranded nucleic acids comprising sense-strand nucleic acids and antisense-strand nucleic acids, and including an at least 11-base-pair duplex strand region; wherein an oligonucleotide strand of at least 17 nucleotides and no more than 30 nucleotides long in the antisense-strand nucleic acids is complementary with a target APCS mRNA sequence including a base sequence represented by any of SEQ ID NOS. 1288–1930.
(FR) La présente invention concerne des acides nucléiques bicaténaires qui suppriment l'expression du gène APCS, les acides nucléiques bicaténaires comprenant des acides nucléiques à brin sens et des acides nucléiques à brin antisens, et comprenant une région de brin duplex à au moins 11 paires de bases ; un brin oligonucléotidique d'au moins 17 nucléotides et pas plus de 30 nucléotides de long dans les acides nucléiques à brin antisens étant complémentaire d'une séquence d'ARNm d'APCS cible comprenant une séquence de base représentée par l'une des SEQ ID NOS. 1288–1930.
(JA) 本発明は、センス鎖核酸及びアンチセンス鎖核酸からなり、少なくとも11個の塩基対の二重鎖領域を含む二本鎖核酸であって、前記アンチセンス鎖核酸中の、少なくとも17個のヌクレオチドかつ多くとも30個のヌクレオチドの鎖長のオリゴヌクレオチド鎖において、配列番号1288~1930のいずれかで表される塩基配列を含む標的APCS mRNA配列と相補的である、APCS遺伝子の発現を抑制させる二本鎖核酸、を提供する。
Designated States: AE, AG, AL, AM, AO, AT, AU, AZ, BA, BB, BG, BH, BN, BR, BW, BY, BZ, CA, CH, CL, CN, CO, CR, CU, CZ, DE, DJ, DK, DM, DO, DZ, EC, EE, EG, ES, FI, GB, GD, GE, GH, GM, GT, HN, HR, HU, ID, IL, IN, IR, IS, JO, JP, KE, KG, KH, KN, KP, KR, KW, KZ, LA, LC, LK, LR, LS, LU, LY, MA, MD, ME, MG, MK, MN, MW, MX, MY, MZ, NA, NG, NI, NO, NZ, OM, PA, PE, PG, PH, PL, PT, QA, RO, RS, RU, RW, SA, SC, SD, SE, SG, SK, SL, SM, ST, SV, SY, TH, TJ, TM, TN, TR, TT, TZ, UA, UG, US, UZ, VC, VN, ZA, ZM, ZW
African Regional Intellectual Property Organization (ARIPO) (BW, GH, GM, KE, LR, LS, MW, MZ, NA, RW, SD, SL, ST, SZ, TZ, UG, ZM, ZW)
Eurasian Patent Office (AM, AZ, BY, KG, KZ, RU, TJ, TM)
European Patent Office (EPO) (AL, AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HR, HU, IE, IS, IT, LT, LU, LV, MC, MK, MT, NL, NO, PL, PT, RO, RS, SE, SI, SK, SM, TR)
African Intellectual Property Organization (BF, BJ, CF, CG, CI, CM, GA, GN, GQ, GW, KM, ML, MR, NE, SN, TD, TG)
Publication Language: Japanese (JA)
Filing Language: Japanese (JA)